| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/28/2017 | UroGen Pharma Ltd. | URGN | Sale | Ordinary Shares, par value NIS 0.01 per share | 177.8k | $40.51 | $7.2M | | 11/27/2017 |
| 11/27/2017 | UroGen Pharma Ltd. | URGN | Sale | Ordinary Shares, par value NIS 0.01 per share | 31.5k | $41.12 | $1.3M | | 11/27/2017 |
| 05/15/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Other (disposition) | Common Stock $0.001 par value | 3.6M | $0.00 | $0 | By ProQuest Investments IV, L.P. | 05/15/2017 |
| 05/15/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Other (acquisition) | Common Stock $0.001 par value | 149.1k | $0.00 | $0 | By Jay Moorin directly and through IRA | 05/15/2017 |
| 04/25/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 51.2k | $88.34 | $4.5M | By ProQuest Financial LLC | 04/25/2017 |
| 04/25/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 3k | $89.09 | $263.8k | By ProQuest Financial LLC | 04/25/2017 |
| 04/25/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Stock Option (right to buy) | 2.3k | $0.90 | $2.1k | By ProQuest Financial LLC | 04/25/2017 |
| 04/25/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Stock Option (right to buy) | 2.3k | $4.04 | $9.5k | By ProQuest Financial LLC | 04/25/2017 |
| 04/25/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Stock Option (right to buy) | 2.3k | $8.78 | $20.5k | By ProQuest Financial LLC | 04/25/2017 |
| 04/25/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Stock Option (right to buy) | 3.1k | $4.42 | $13.8k | By ProQuest Financial LLC | 04/25/2017 |
| 04/25/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Stock Option (right to buy) | 9.4k | $12.67 | $118.6k | By ProQuest Financial LLC | 04/25/2017 |
| 04/25/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Stock Option (right to buy) | 10k | $46.09 | $460.9k | By ProQuest Financial LLC | 04/25/2017 |
| 04/25/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Stock Option (right to buy) | 20k | $59.31 | $1.2M | By ProQuest Financial LLC | 04/25/2017 |
| 04/03/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 61.4k | $83.13 | $5.1M | By ProQuest Investments IV, L.P. | 03/30/2017 |
| 03/31/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 23.7k | $83.02 | $2M | By ProQuest Investments IV, L.P. | 03/30/2017 |
| 03/30/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 6.2k | $83.00 | $516.5k | By ProQuest Investments IV, L.P. | 03/30/2017 |
| 03/29/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 58.8k | $83.01 | $4.9M | By ProQuest Investments IV, L.P. | 03/27/2017 |
| 03/29/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 500 | $83.01 | $41.5k | By ProQuest Financial LLC | 03/27/2017 |
| 03/29/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 1.6k | $83.01 | $132.8k | By Jay Moorin through IRA | 03/27/2017 |
| 03/28/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 6.2k | $83.02 | $513.2k | By ProQuest Investments IV, L.P. | 03/27/2017 |
| 03/27/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 37.7k | $83.00 | $3.1M | By ProQuest Investments IV, L.P. | 03/27/2017 |
| 03/27/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 1.3k | $83.00 | $107.9k | By Jay Moorin through IRA | 03/27/2017 |
| 03/27/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 400 | $83.00 | $33.2k | By ProQuest Financial LLC | 03/27/2017 |
| 03/23/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 700 | $83.01 | $58.1k | By ProQuest Investments IV, L.P. | 03/21/2017 |
| 03/21/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 500 | $83.10 | $41.6k | By ProQuest Investments IV, L.P. | 03/21/2017 |
| 03/20/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 51.9k | $82.10 | $4.3M | By ProQuest Investments IV, L.P. | 03/16/2017 |
| 03/17/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0,001 par value | 39k | $82.01 | $3.2M | By ProQuest Investments IV, L.P. | 03/16/2017 |
| 03/16/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 9.1k | $82.08 | $748.6k | By ProQuest Investments IV, L.P. | 03/16/2017 |
| 01/04/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 65.1k | $85.16 | $5.5M | By ProQuest Investments IV, L.P. | 01/04/2017 |
| 11/11/2016 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 15.6k | $85.00 | $1.3M | By ProQuest Investments IV, L.P. | 11/10/2016 |
| 11/10/2016 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 15.4k | $85.10 | $1.3M | By ProQuest Investments IV, L.P. | 11/10/2016 |
| 11/10/2016 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 167 | $86.00 | $14.4k | By ProQuest Investments IV, L.P. | 11/10/2016 |
| 11/10/2016 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 100 | $86.06 | $8.6k | By ProQuest Investments IV, L.P. | 11/10/2016 |
| 11/10/2016 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 1.7k | $87.05 | $148k | By ProQuest Investments IV, L.P. | 11/10/2016 |
| 11/10/2016 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock $0.001 par value | 300 | $85.00 | $25.5k | By ProQuest Financial LLC | 11/10/2016 |
|